For our Pharmacy Information System FarmaSys we released release 5.2 this month. Besides smaller updates such as the connection of the administration registration of CareXS, this release contains the following main developments:
MFA interactions
The main part of this release concerns the implementation of the new MFB interactions from the G-Standard. In total there are 3,611 possible interactions. The purpose of the MFBs is to make the signaling more relevant by involving more patient characteristics. This is the first important step in the new way of medication monitoring. In total there are about 7,000 MFBs in the G-standard; it is expected that in the coming years the functionalities of the MFBs will be further extended, among others with contraindications.
Look at the leaflet
The KIJKsluiter is fully operational with release 5.2. After purchasing a subscription to KIJKsluiter, it can now be activated in FarmaSys.
The user can send a Sight-Link to the patient directly from FarmaSys. (This requires a validated e-mail address).
As a FarmaSys user, do you have any questions about this release or the releases you have received? Please contact us.
